CIBC World Market’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-9,369
| Closed | -$257K | – | 1317 |
|
2024
Q3 | $257K | Buy |
+9,369
| New | +$257K | ﹤0.01% | 1094 |
|
2019
Q1 | – | Sell |
-7,106
| Closed | -$207K | – | 1120 |
|
2018
Q4 | $207K | Sell |
7,106
-1,258
| -15% | -$36.6K | ﹤0.01% | 952 |
|
2018
Q3 | $385K | Sell |
8,364
-2,852
| -25% | -$131K | ﹤0.01% | 874 |
|
2018
Q2 | $419K | Sell |
11,216
-12,544
| -53% | -$469K | ﹤0.01% | 855 |
|
2018
Q1 | $702K | Buy |
23,760
+16,263
| +217% | +$480K | ﹤0.01% | 710 |
|
2017
Q4 | $257K | Buy |
7,497
+62
| +0.8% | +$2.13K | ﹤0.01% | 647 |
|
2017
Q3 | $269K | Sell |
7,435
-27,971
| -79% | -$1.01M | ﹤0.01% | 615 |
|
2017
Q2 | $915K | Buy |
+35,406
| New | +$915K | ﹤0.01% | 639 |
|
2014
Q1 | – | Sell |
-9,890
| Closed | -$207K | – | 722 |
|
2013
Q4 | $207K | Buy |
+9,890
| New | +$207K | ﹤0.01% | 639 |
|